|
Ronald W. Kim
Ronald W. Kim served in the United States Navy from 1970 through 1972.Mr. Kim attended the University of Florida and received his Bachelor of Science in Business Administration with a major in Accounting, and attended the University of Memphis School of
Law and received his Juris Doctor in 1980.
Mr. Kim is the owner of the Memphis based law firm of RON KIM LAW, an Association of Trial Lawyers and has offices in Tennessee, Florida and Alabama. His legal practice focuses on injury, business, and intellectual property, biotech and health law matters. Mr. Kim is admitted to practice in Tennessee, Alabama and Florida courts. Mr. Kim is a member of the Tennessee Bar Association including the sections of Alternative Dispute Resolution and Health Law, Memphis Shelby County Bar Association, including the section of Alternative Dispute Resolution, Florida Bar Association, Alabama Bar Association, including the section of Health Law. The Alabama Center for Dispute Resolution has registered Mr. Kim on it’s Alabama Mediator and Arbitrator rosters.
Mr. Kim is admitted to practice in the following federal courts: United States Tax Court, United States District Court Northern District of Mississippi, United States District Court Western and Middle Districts of Tennessee and the United States District Court Northern District of Florida, United States District Court, Eastern and Western Districts of Arkansas. Mr. Kim is a Tennessee Supreme Court Rule 31 Certified Mediator and is Registered on the Alabama State Court Mediator and Arbitrator Roster.
Mr. Kim has a number of years of experience defending individuals and insurance carriers with respect to personal injury claims. He has litigated to judgment and/or settled thousands of cases representing injured parties. In addition he has litigated or resolved intellectual property matters, including but not limited to those dealing with confidentiality and non-compete clauses.
Mr. Kim was a co-founder of the Biotech Company, Viral Antigens
Inc., and was in-house counsel for that Company for many years.
Viral Antigens Inc. was subsequently purchased by a public company,
Meridian BioSciences, Inc. Mr. Kim is well versed in intellectual
property law and has negotiated complex contracts for the production
of early phase vaccines and has negotiated biotechnology
manufacturing and licensing agreements with private and public
pharmaceutical and diagnostics companies worldwide.
|
 |
